Member Info for Jimzi

Not suprising if 5 year MOUs are the norm in Africa.

Worth asking about if anyone can be arsed .

Good.

Who the hell wants a 5 year MOU - what the hell is a 5 yr MOU from inception? Utter nonsense

whole market took a turn down around miday - my list suddenly became red.

not looking to healthy atm
6.09 v 6.34 for 200k.

Cheers.Yes, saw the rev per patient forecast - from feedback or sales literature based on savings budget examples given - we will have to wait as unfortunatley no ref given to this but expectation seems reasonable.to me.
I think / hope the burn rate should be modest atm.

I assume the actual cost to make ipriclam is low ?

Good summary. esp the competitor cost comparaision.

What is the monthly cash burn at this stage of the company\;s activities - atm I assume its just admin costs?

i.e do they need more funds than just warrants being exercised and for what?

another bloody transfer coming. 58p my guess.
Wish they would do them all in one go.

Sbs don’t go through the market unless provider short of stock So no, I’m not dreaming and take it very seriously, it’s money.

there's big volume - there isn;t .

100k sb at 7.71 for me.

I'm happy

Take away additions and its a 20% drop [in 1 year]

NAV is stick your finger in the air job.

Drop for last yr full results

Have a punt by all means - but unless you know the plan - its risky - it could de-list - then you have a world of hurt - the assets have been de-valued significantly on what appears highly speculative valuation methods.

How is the mcap justified - the bod might know but you can't justify it from these accounts imo

1546?

DESIgned to go down. Downbeat but I’ve added shares- misdirection. Assets devalued by 35m. Deferred tax unchanged though so that doesn’t add up. And why is there DT anyway (65m) Nothing adds up so yes, they are up to something as per our beloved Market. The only way you’d find out what’s really going on is to go to Africa to find out- a project no PI will do. So uninvestable imo.

You seem to buy first and then read RNS 8 months later - an interesting strategy. - not that I will follow but GL though.

If you hadn’t considered the great nominal debate, you ain’t the sharpest button when trading. It’s bleeding obvious

From the RNS Based on the results of two Phase IIb trials and previous studies, FLU-v is now ready for Phase III development. Can we rely on nomads.? Most mysterious share I’ve come across but fun if not a tad dull.

and WSG had the choice of Iran airport contracts with potential national coverage or a contract to build a wall between the US and Mexico,, who would have gone for the latter?

Todays choice is - should they raise 450k to continue with the project or just walk away?

Its a high risk share doused in global volatility juice.

iis unchanged

https://uk.reuters.com/business/stocks/financial-highlights/CAPX.L